NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES
27. März 2024 08:30 ET
|
Lixte Biotechnology Holdings, Inc.
LB-100 IS SYNERGISTIC WITH WEE1 INHIBITION IN KILLING CANCER CELLS; FINDING OPENS NEW TREATMENT STRATEGY IN ADDITION TO THREE CURRENT LIXTE CLINICAL TRIALS PASADENA, CA, March 27, 2024 (GLOBE...
Small Cell Lung Cancer Therapeutics Market Value to Exceed of USD 12.9 Bn by 2031, rising at a 11.9% CAGR: TMR Report
05. Mai 2023 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 05, 2023 (GLOBE NEWSWIRE) -- The global small cell lung cancer therapeutics market was valued at USD 4.6 Bn in 2022 and is projected to expand at a CAGR of...
Qualigen Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
12. Dezember 2022 08:30 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for...
Solid Tumour Testing Market Size is projected to reach USD 40 Billion by 2030, growing at a CAGR of 6.2%: Straits Research
16. August 2022 11:30 ET
|
Straits Research
New York, United States, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Solid Tumors Form when cancerous tissues accumulate. Solid tumors are not cystic or liquid. Depending on their characteristics, solid...
Provectus Announces Presentation of Initial Results from Phase 1B Trial of PV-10® in Combination with KEYTRUDA® for Treatment of Checkpoint-Refractory Advanced Melanoma at SMR 2019 Congress
21. November 2019 10:19 ET
|
Provectus Biopharmaceuticals Inc.
First 10 checkpoint-refractory melanoma patients treatedEstablished safety profiles of PV-10 and KEYTRUDA were maintained20% ORR and 40% DCR (RECIST 1.1)Changes in immune system activation biomarkers...
ALGAE DYNAMICS CORP SECURES US $250,000 INVESTMENT FROM TEEWINOT LIFE SCIENCES CORPORATION
15. November 2017 09:00 ET
|
Algae Dynamics Corporation
Toronto, ON, Nov. 15, 2017 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: ADYNF) (the "Company"), a developer of unique health products utilizing cannabis and...